Use of a carbocyanine dye as a marker of functional vasculature in murine tumours
about
Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivityQuantification of tumour vasculature and hypoxia by immunohistochemical staining and HbO2 saturation measurements.Early spatial and temporal changes in tumour perfusion after administration of flavone acetic acid.Tumor vascular maturation and improved drug delivery induced by methylselenocysteine leads to therapeutic synergy with anticancer drugsTracking Antibody Distribution with Near-Infrared Fluorescent Dyes: Impact of Dye Structure and Degree of Labeling on Plasma Clearance.Modification of tumour radiation response in vivo by the benzamide analogue pyrazinamide.Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia and enhances efficacy of radiotherapy in murine tumor modelsMultichannel imaging to quantify four classes of pharmacokinetic distribution in tumorsEffect of vascular marker Hoechst 33342 on tumour perfusion and cardiovascular function in the mouse.The use of vascularised spheroids to investigate the action of flavone acetic acid on tumour blood vesselsIn vivo cancer imaging by poly(ethylene glycol)-b-poly(ɛ-caprolactone) micelles containing a near-infrared probe.Necrosis in non-tumour tissues caused by flavone acetic acid and 5,6-dimethyl xanthenone acetic acid.Hydroethidine: a fluorescent redox probe for locating hypoxic cells in spheroids and murine tumours.Determinants of anti-vascular action by combretastatin A-4 phosphate: role of nitric oxide.Zonal image analysis of tumour vascular perfusion, hypoxia, and necrosis.Transient perfusion in human melanoma xenografts.Endogenous stimuli-sensitive multistage polymeric micelleplex anticancer drug delivery system for efficient tumor penetration and cellular internalization.Lectin intravital perfusion studies in tumor-bearing mice: micrometer-resolution, wide-area mapping of microvascular labeling, distinguishing efficiently and inefficiently perfused microregions in the tumor.Alterations in daily sequencing of axitinib and fractionated radiotherapy do not affect tumor growth inhibition or pathophysiological response.Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin.Tumour hypoxia: the picture has changed in the 1990s.The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: an autoradiographic study.Henry S. Kaplan Distinguished Scientist Award Lecture 2007. The remarkable yin and yang of tumour hypoxia.Intravascular HBO(2) saturations, perfusion and hypoxia in spontaneous and transplanted tumor models.Use of labeled tomato lectin for imaging vasculature structures.Activity of the hypoxia-activated pro-drug TH-302 in hypoxic and perivascular regions of solid tumors and its potential to enhance therapeutic effects of chemotherapy.Contribution of transient blood flow to tumour hypoxia in mice.Fluorescently Labeled Branched Polymers and Thermal Responsive Nanoparticles for Live Cell ImagingHeterogeneous distribution of trastuzumab in HER2-positive xenografts and metastases: role of the tumor microenvironment
P2860
Q28364955-17F2BE23-6133-48AF-A5EB-E867C154EE71Q30636636-4711813C-AB5B-431D-AD8D-61DEE2289D44Q30817970-A7F88052-E6D0-4FB3-82AC-E9CEA056CD30Q33344362-4A4006DA-CB07-44F2-89C4-AB6B80DA50B9Q33635071-1200F770-EB2A-4004-9B88-0DBB266E1D8DQ33861033-57C74D29-C102-4C64-B18E-E4F6656CBE68Q33879424-D32724AE-9158-44F3-B3F7-285B6711FDFEQ34241923-464156DE-4496-4240-838D-7444377E0759Q34263859-3D01B835-28E2-47DA-82C3-DFF85F45CC7AQ34836081-8185DE8F-45D0-47F8-B1EE-C3DCEAE87925Q35350213-A0C65FD0-DF75-4DF0-9D36-F5212359334FQ35982301-5D1F0718-B805-44F6-91AE-C6513F932326Q36207258-619AC42A-3A8B-46EC-BB38-C5E93FD9A6DFQ36621895-60F77308-6F92-4660-AA48-32B39B4DE841Q36644587-D18725DA-2AEA-4C9A-9C88-9A90ED6F6612Q36678044-4BE81401-FB76-43CB-8AC8-C3F7C1F6E80AQ38837183-54A30CA0-E1D3-4147-8C51-FFA80A8F58CDQ39465812-2E45F848-BDA0-4CDF-84A6-4E18E30ABE96Q39828661-0254FEB3-9011-4FEE-922E-6D69AF473AB3Q40063984-381EAE5E-96A3-46E1-9501-D30388784D00Q40620931-437D328A-3609-415A-9C22-3CDF23207D2DQ41130349-EB9ACDAE-7628-4382-92BD-423C26CC36F4Q43009524-A1EE333E-AACC-43CB-9ADA-C93ACF19E9C7Q43690873-E1453456-6416-4BE7-8D03-F2E810CA8547Q45987179-802EDBC1-EB19-4233-AC9B-ED80A0EBB261Q46922239-1C840364-24F6-4BE7-A48A-956ED2AFC577Q54186132-9DC87BB5-53E7-48B4-AA13-5052BEF3B3C7Q57342782-F3066E84-59AE-4B22-B923-798E81FD117BQ58698483-72744DCA-DACB-4115-B58F-017190ECF61F
P2860
Use of a carbocyanine dye as a marker of functional vasculature in murine tumours
description
1989 nî lūn-bûn
@nan
1989 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Use of a carbocyanine dye as a marker of functional vasculature in murine tumours
@ast
Use of a carbocyanine dye as a marker of functional vasculature in murine tumours
@en
type
label
Use of a carbocyanine dye as a marker of functional vasculature in murine tumours
@ast
Use of a carbocyanine dye as a marker of functional vasculature in murine tumours
@en
prefLabel
Use of a carbocyanine dye as a marker of functional vasculature in murine tumours
@ast
Use of a carbocyanine dye as a marker of functional vasculature in murine tumours
@en
P2093
P2860
P356
P1476
Use of a carbocyanine dye as a marker of functional vasculature in murine tumours
@en
P2093
D J Chaplin
M J Trotter
P2860
P2888
P304
P356
10.1038/BJC.1989.148
P407
P577
1989-05-01T00:00:00Z